Strides Pharma share price falls over 3% on plans to spin off CDMO, gelatin biz into separate entity

  • Strides Pharma said its board has approved a scheme of arrangement among group entities to combine identified CDMO business of Strides, the identified CDMO business of Steriscience and the soft gelatin business under Stelis under one entity called OneSource.

Livemint, Edited By Ankit Gohel
Published26 Sep 2023, 10:47 AM IST
Trade Now
Strides Pharma share price was down 5.5% from its 52-week high of  <span class='webrupee'>₹</span>549.00 apiece hit on September 25.
Strides Pharma share price was down 5.5% from its 52-week high of ₹549.00 apiece hit on September 25.(Photo: Company Website)

Strides Pharma Science share price declined over 3% in early trade on Tuesday after the company announced to spin off its CDMO (Contract Development and Manufacturing Organisation) and soft gelatin businesses into a new entity. Strides Pharma shares fell as much as 3.22% to Rs 518.40 apiece on the BSE.

Strides Pharma share price was down 5.5% from its 52-week high of 549.00 apiece hit on September 25.

In a regulatory filing on Monday, the company said its board has approved a scheme of arrangement among group entities to combine identified CDMO business of Strides, the identified CDMO business of Steriscience and the soft gelatin business under Stelis under one entity called OneSource.

Also Read: Tata Steel share price rises 2% as Moody's upgrades Tata Steel's corporate family rating to Baa3, outlook stable

The company's board intends to build a specialty pharmaceutical contract development and manufacturing organisation with capabilities in biologics, oral soft-gels, complex injectables, sterile injectables, including other complex drug delivery systems, Strides Pharma Science said.

In this regard, it is proposed to combine the identified CDMO business of Strides and the identified CDMO business of Steriscience under Stelis, it added.

The new platform will be able to offer development and manufacturing services covering platform technologies, speciality injectables, complex generics, biosimilars, and biologics, it added.

Exciting news! Mint is now on WhatsApp Channels :rocket: Subscribe today by clicking the link and stay updated with the latest financial insights! Click here!

“We expect this company to be formed through the NCLT process in the next 12 to 18 months considering that there are multiple companies being merged and demerged into the structure,” Strides Pharma Science Executive Chairperson and Managing Director Arun Kumar said in a conference call.

More importantly, the company will end up in the next three to four years as a very powerful CDMO entity in the pharma space, he added.

As per the swipe ratio of 1:2, Strides Pharma shareholders would receive 1 share of OneSource for every 2 shares of Strides. The implied value of proposed shares issued by OneSource to Stride's shareholders is 364 per share.

As part of the process, Strides shareholders will own 44% of OneSource. The scheme of arrangement is expected to be completed by April 1, 2024.

Strides expects the OneSource business to achieve sales between $180-200 million in FY25.

Also Read: Coforge, Newgen plan to offer new solutions to insurance cos

As part of the process, Strides will demerge the oral soft gelatin business and identified the CDMO business into Stelis. Upon demerger, the shares of Stelis held by Strides will be cancelled, and shareholders of Strides will become shareholders of Stelis.

SteriScience, the promoter group company, will demerge sterile injectables CDMO business into Stelis.

Pursuant to the demerger, Stelis will issue equity shares to the shareholders of Strides and SteriScience on the recommended share entitlement ratio determined by an independent valuer, Strides Pharma Science noted.

At 10:45 am, Strides Pharma shares were trading 0.62% higher at 538.95 apiece on the BSE.

Catch Live Market Updates here

(With inputs from PTI)

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:26 Sep 2023, 10:47 AM IST
Business NewsMarketsStock MarketsStrides Pharma share price falls over 3% on plans to spin off CDMO, gelatin biz into separate entity

Most Active Stocks

Bandhan Bank share price

211.00
03:51 PM | 11 OCT 2024
23.25 (12.38%)

Tata Steel share price

160.70
03:51 PM | 11 OCT 2024
1.05 (0.66%)

Axis Bank share price

1,174.25
03:29 PM | 11 OCT 2024
-9.5 (-0.8%)

Zee Entertainment Enterprises share price

130.10
03:55 PM | 11 OCT 2024
0.7 (0.54%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Cummins India share price

3,611.75
03:55 PM | 11 OCT 2024
-169.6 (-4.49%)

Star Health and Allied Insurance share price

547.85
03:59 PM | 11 OCT 2024
-19.35 (-3.41%)

Creditaccess Grameen share price

1,081.40
03:29 PM | 11 OCT 2024
-38 (-3.39%)

Jubilant Pharmova share price

1,146.15
03:55 PM | 11 OCT 2024
-37.65 (-3.18%)
More from Top Losers

Nippon Life share price

700.85
03:53 PM | 11 OCT 2024
59.15 (9.22%)

Network 18 Media & Investments share price

81.44
03:52 PM | 11 OCT 2024
5.16 (6.76%)

Sonata Software share price

608.50
03:42 PM | 11 OCT 2024
36.1 (6.31%)

Triveni Turbines share price

790.10
03:29 PM | 11 OCT 2024
45.85 (6.16%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    76,645.000.00
    Chennai
    76,651.000.00
    Delhi
    76,803.000.00
    Kolkata
    76,655.000.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.76/L0.00
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00

    Popular in Markets

      HomeMarketsPremiumInstant LoanMint Shorts